AYTU BIOPHARMA, INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Aytu Biopharma, Inc annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2010 to Q3 2023.
  • Aytu Biopharma, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2023 was -$2.73M, a 120% decline year-over-year.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$1.26M, a 114% decline from 2023.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $8.87M, a 480% increase from 2022.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.53M, a 95% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$2.73M -$16.3M -120% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 $13.6M +$19M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q3 2021 -$5.46M -$3.29M -151% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q3 2020 -$2.18M -$2.18M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q3 2018 $0 -$10.4M -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q3 2017 $10.4M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q4 2014 $16K +$10.6K +194% Sep 1, 2014 Nov 30, 2014 10-Q 2015-01-12
Q4 2013 $5.44K -$4.07K -42.8% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-12
Q4 2012 $9.51K +$773 +8.85% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-10
Q4 2011 $8.74K -$2.51K -22.3% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-14
Q4 2010 $11.2K Sep 1, 2010 Nov 30, 2010 10-Q 2011-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.